论文部分内容阅读
系膜增生性肾炎(Mesangial proliferativeglomerulonephritis,简称MsPGN)是临床上最常见的病理类型,1989-01～1997-10月期间笔者等应用激素(Predisone)、雷公藤(Tripterygium WilfordiiHook F)、血管紧张素转换酶抑制剂(Angiotensinconverting enzyme inhibition,简称ACEI)及抗凝(Anticoagulation)四者联合(简称PTAA方案)治疗此病患者54例,疗效满意,现报告如下:1 对象与方法1.1 对象 均经肾活检确诊为原发性MsPGN,呈弥漫系膜增生伴或/不伴局灶节段性肾小球硬化(Focal segmental glomerular sclerosis,简称FSGS)。本组中男40例、女14例,年龄4～55 y,病程10 d～
Mesangial proliferative glomerulonephritis (Mesangial proliferative glomerulonephritis, referred to as MsPGN) is the most common pathological types of clinical, from 1989 to 01 ~ 1997-10 months, the author applied the hormone (Predisone), Tripterygium (Tripterygium WilfordiiHook F), angiotensin conversion 54 patients with the disease were treated by the combination of the four inhibitors of angiotensin-converting enzyme (ACEI) and anticoagulation (referred to as PTAA), the results are as follows: 1 Subjects and methods 1.1 Subjects were confirmed by renal biopsy The primary MsPGN is diffuse mesenteric hyperplasia with or without focal segmental glomerular sclerosis (FSGS). The group of 40 males and 14 females, age 4 ~ 55 y, duration of 10 d ~